Biotechnology APAC News & Press Release Distribution

Biotechnology

All
Global

AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego

HAMILTON ON, Aug. 24, 2022 /PRNewswire/ -- AtomVie Global Radiopharma Inc. ("AtomVie") today announced the successful closing of its Series A financing with Avego Management, LLC ("Avego"), a healthcare investment firm. AtomVie is a global leading CDMO (Contract Development and Manufacturing Orga...

2022-08-24 21:00 3323

AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego

MGI Supports the Ministry of Health of Indonesia in the Country's Breakthrough National Genome Project

JAKARTA, Indonesia, Aug. 24, 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, today announced that the National Genome Project inIndonesia has selected MGI technology* as one of the technology providers for the first phase of its effort towards establishin...

2022-08-24 17:34 3361

First US Patient Enrolled in SELUTION SLR IDE Peripheral Study

GENEVA, Switzerland, Aug. 24, 2022 /PRNewswire/ -- The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approval in the ...

2022-08-24 09:00 2660

First US Patient Enrolled in SELUTION SLR IDE Peripheral Study

Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) in Patients with Advanced Malignancies

ROCKVILLE, Md. and SUZHOU, China, Aug. 23, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2022-08-24 08:00 3019

Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results

Additions to executive team strengthen global leadership and position Company for strategic long-term growth First-ever product launch of long-acting amubarvimab/romlusevimab combination therapy for COVID-19 inChina advances Brii Bio from clinical development to commercial stage biotechnology co...

2022-08-24 07:30 3541

Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results

MGI Honored with 2022 Stevie® Award for Most Valuable COVID-19 Corporate Response

SHENZHEN, China, Aug. 23, 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, was named the winner of a Silver Stevie® Award for Most Valuable Corporate Response in the COVID-19 category as part of the 19th Annual International Business Awards. This marked t...

2022-08-23 18:27 2009

Firmenich Receives SBTi Approval For Net-Zero Emissions Target

Firmenich is the first company in the industry to receive approval from the Science Based Targets initiative (SBTi) for its net-zero emissions target GENEVA, Aug. 23, 2022 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, has received approval from the S...

2022-08-23 18:00 1771

Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals

LISBON, Portugal, Aug. 23, 2022 /PRNewswire/ -- Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary supplements suffer from low solubility. This results in poor...

2022-08-23 17:58 1276

Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head

Building a leadership team with global and local experience and expertise to enable rapid execution across Company's broad therapeutic strategy DURHAM, N.C. and BEIJING, Aug. 23, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock ...

2022-08-23 07:30 3160

Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases

Albert Wu, MD, PhD, a recognized advocate of using stem cell therapy to treat eye conditions, will advise company's development of ocular tissue rejuvenation therapeutics MOUNTAIN VIEW, Calif., Aug. 22, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA ...

2022-08-22 20:00 2377

Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases

U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17

* Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. * Doses of the Novavax COVID-19 Vaccine, Adjuvanted are now available and primary series immunizations for adolescents can beginonce a policy recommendation from the CDC is received GAITHERSBURG, Md., Aug. 2...

2022-08-22 10:05 2995

Menarini Group's Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer

* Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union * Submission supported by results from the pivo...

2022-08-19 18:15 2183

Angel Yeast Brings Latest Innovative Products and Solutions to FIC 2022

GUANGZHOU, China, Aug. 19, 2022 /PRNewswire/ -- Angel Yeast , (SH600298), a globally listed yeast and yeast extract manufacturer, showcased its latest yeast and yeast extract products, health ingredients, and fermentation ingredients alongside its wide range of innova...

2022-08-19 15:50 2186

Angel Yeast Brings Latest Innovative Products and Solutions to FIC 2022

Minderoo Foundation and Illumina Commit $40M to Apply Advanced Genomics to Marine Conservation

New partnership will use the power of high-throughput sequencing to measure and understand marine life in our oceans at a rate that eclipses traditional research methods SAN DIEGO, Aug. 19, 2022 /PRNewswire/ -- Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a40 million Au...

2022-08-19 10:45 1410

Henlius 2022 H1 Results: Sharpen all-round edges, advance in evolution to Biopharma

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its 2022 interim results. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched inChina, 1 in ...

2022-08-18 21:35 2756

Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Jemincare, a leading pharmaceutical company fromChina, announced today that it and its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., have entered into an exclusive worldwide license agreement with Roche (SIX: RO, ROG; OTCQX: ...

2022-08-18 15:25 2295

TurtleTree Announces LF+, the First-Ever Sustainable Lactoferrin Made With Precision Fermentation

WOODLAND, Calif. and SINGAPORE, Aug. 17, 2022 /PRNewswire/ -- Following 18 months of extensive R&D, TurtleTree has officially announced its production of LF+, the world's ﬁrst sustainable bovine lactoferrin created using precision fermentation technology.

2022-08-17 22:00 4174

TurtleTree Announces LF+, the First-Ever Sustainable Lactoferrin Made With Precision Fermentation

JOYSBIO HAS DEVELOPED NEW MONKEYPOX RAPID TESTS

JOYSBIO, one of the world's leading manufacturers of rapid test kits, has developed two new Monkeypox tests that deliver results in 15 minutes TIANJIN, China, Aug. 17, 2022 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid test kits, is proud to announce the...

2022-08-17 14:30 2457

Global Cord Blood Corporation Files Annual Report on Form 20-F

HONG KONG, Aug. 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...

2022-08-17 04:16 2698

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML

Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approximately one-third of all patients with AML Entospletinib is currently being studied in the Phase 3 AGILITY registrational study, with data anticipated in seco...

2022-08-17 04:05 2535

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML

1 ... 62 63 646566 67 68 ... 167